New Data Presented at ESMO 2016 Further Demonstrates XTANDITM▼ (enzalutamide) Significantly Improves Time to PSA Progression in Advanced Prostate Cancer, Compared with Placebo

… with nonrising prostate-specific antigen in
patients with metastatic castration-resistant prostate cancer (mCRPC)
in … . Prostate Cancer Tests. Available at: http://www.cancerresearchuk.org/about-cancer/type/prostate-cancer/diagnosis/prostate-cancer-tests.
[Accessed …